Clementia pharmaceuticals inc. (CMTA)
Balance Sheet / Quarterly
Sep'18Jun'18Mar'18Dec'17Dec'16
Current assets
Cash

12,056

12,937

26,638

36,230

9,434

Short-term investments

70,000

55,000

30,000

30,000

30,000

Interest receivable

181

1,402

961

575

307

Sales tax and other receivables

168

71

113

94

90

Income tax and tax credits receivable

1,044

1,205

1,093

977

139

Prepaid expenses

4,609

5,907

2,366

3,023

652

Total current assets

88,060

76,523

61,173

70,901

40,624

Non-current assets
Long-term investments

25,000

50,000

75,000

75,000

0

Long-term prepaid expenses

733

-

-

775

-

Property and equipment

18

23

28

33

38

Intangible assets

1,570

1,619

1,667

1,715

894

Total non-current assets

27,322

51,642

76,695

77,524

932

Total assets

115,383

128,166

137,869

148,425

41,557

Current liabilities
Accounts payable and accrued liabilities

8,792

8,455

8,661

6,718

4,521

Income taxes payable

-

-

-

-

2

Total current liabilities

-

-

-

-

4,523

Preferred shares

-

-

-

-

67,880

Embedded derivatives

-

-

-

-

117,824

Total non-current liabilities

-

-

-

-

185,705

Total liabilities

8,792

8,455

8,661

6,718

190,229

Equity
Common shares

230,659

230,659

230,659

230,659

272

Contributed surplus

6,319

4,663

3,391

2,659

498

Deficit

-130,388

-115,611

-104,843

-91,612

-149,442

Total equity

106,590

119,711

129,207

141,706

-148,672

Commitments and contingencies

-

-

-

-

0

Subsequent events

-

-

-

-

0

Total equity and liabilities

115,383

128,166

137,869

148,425

41,557